Call for Applications: ICRF Israel Grant Program

The Israel Cancer Research Fund (ICRF) invites Israeli scientists to apply for research grants supporting basic, translational, and clinical cancer research. With over $100 million USD awarded to date, the ICRF aims to further cancer research through these grants. Applications for the 2027-2028 funding year are open until 30 December 2026, 12:00 PM EST. Opportunity at a Glance

- Provider: Israel Cancer Research Fund (ICRF)

- Opportunity Type: Research Grants

- Funding Amount: Up to $100,000 USD per year

- Eligible Applicants: Israeli scientists at sponsoring Israeli institutions

- Eligible Countries: Israel

- Application Deadline: 30 December 2026, 12:00 PM EST

- Project Duration: Three to five years, depending on the grant type

About the Opportunity

The ICRF Israel Grant Program is designed to fund exceptional cancer research conducted by Israeli scientists. These grants aim to support innovative projects with high scientific merit and potential to significantly advance cancer understanding, prevention, diagnosis, or treatment. Funding and Benefits - Research Career Development Awards (CDAs): Up to $45,000 USD per year for three years, non-renewable.

- Project Grants: Up to $60,000 USD per year for three years, intended for established investigators.

- Research Professorship Grants: Up to $100,000 USD per year for five years, awarded to accomplished professors.

Who Is Eligible? - Applicants: Must be Israeli citizens holding a position at an Israeli institution capable of providing necessary research infrastructure and oversight. - For CDAs: Candidates must have a doctoral degree, at least three years of postdoctoral experience, and be within five years of their initial appointment to a junior position.

- For Project Grants: Independent investigators with demonstrated expertise and leadership in cancer research.

- For Professorship Grants: Full Professors or equivalent with a minimum of eight years of research experience post-PhD, MD, or MD/PhD.

Eligible Activities or Priority Areas - Projects should focus on human cancer-related questions with strong supporting data. - Interdisciplinary approaches and multi-investigator applications are encouraged but not mandatory. - Priority is given to projects likely to impact cancer prevention, diagnosis, or treatment within five to ten years. Why This Opportunity Matters This funding opportunity is crucial for fostering groundbreaking cancer research among Israeli scientists. It supports the development of scientific careers and the advancement of knowledge that could lead to significant breakthroughs in cancer treatment and prevention. How to Apply

- Prepare Application: Gather all required documents and research proposals.

- Submit Online: Use the ICRF’s online application system by the deadline.

- Ensure Compliance: Confirm that your application meets all eligibility and submission criteria.

For detailed application guidelines and to access the online portal, visit the ICRF official website. Frequently Asked Questions Who can apply for the ICRF grants? Israeli citizens affiliated with an Israeli research institution can apply. What is the deadline for application submission? Applications must be submitted by 30 December 2026, 12:00 PM EST. How much funding is available per grant? Funding ranges from $45,000 to $100,000 USD per year, depending on the grant type. Can a Principal Investigator apply for more than one grant? A PI can submit only one application per cycle and may not hold more than one ICRF grant concurrently. What types of research are supported? The grants support basic, translational, and clinical cancer research projects. Next Steps Eligible applicants are encouraged to review the detailed guidelines on the ICRF website and proceed with the application process. Ensure all submissions meet the outlined eligibility criteria and are completed by the specified deadline.